Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 26.58
+1.52 (6.07%)
Oct 31, 2025, 4:08 PM HKT
HKG:1877 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 2,463 | 1,876 | 1,474 | 1,453 | 3,768 | 1,507 | Upgrade |
Other Revenue | 20.21 | 72.73 | 28.4 | - | 257.09 | 87.52 | Upgrade |
| 2,483 | 1,948 | 1,503 | 1,453 | 4,025 | 1,595 | Upgrade | |
Revenue Growth (YoY) | 38.92% | 29.67% | 3.38% | -63.89% | 152.36% | 105.77% | Upgrade |
Cost of Revenue | 547.68 | 523.54 | 634.39 | 526.28 | 1,258 | 376.76 | Upgrade |
Gross Profit | 1,935 | 1,425 | 868.16 | 927.21 | 2,767 | 1,218 | Upgrade |
Selling, General & Admin | 1,549 | 1,508 | 1,381 | 1,294 | 1,377 | 1,128 | Upgrade |
Research & Development | 1,383 | 1,275 | 1,937 | 2,384 | 2,069 | 1,778 | Upgrade |
Other Operating Expenses | 23.46 | 10.35 | 7.54 | 11.75 | 7.07 | 7.72 | Upgrade |
Operating Expenses | 2,952 | 2,779 | 3,344 | 3,690 | 3,453 | 2,913 | Upgrade |
Operating Income | -1,017 | -1,354 | -2,476 | -2,763 | -686.06 | -1,695 | Upgrade |
Interest Expense | -18.44 | -51.35 | -29.01 | -29.37 | -21.83 | -29.39 | Upgrade |
Interest & Investment Income | 10.98 | 43.63 | 173.42 | 61.02 | 30.98 | 20.28 | Upgrade |
Earnings From Equity Investments | - | - | - | -71.03 | - | - | Upgrade |
Currency Exchange Gain (Loss) | 8.27 | 8.27 | -2.66 | -50.05 | -39.94 | -11.67 | Upgrade |
Other Non Operating Income (Expenses) | -9.08 | 29.33 | -38.71 | 117.42 | 0.13 | -0.99 | Upgrade |
EBT Excluding Unusual Items | -1,025 | -1,324 | -2,373 | -2,735 | -716.72 | -1,717 | Upgrade |
Gain (Loss) on Sale of Investments | -4.87 | -71.23 | -149.18 | - | 65.75 | 40.42 | Upgrade |
Gain (Loss) on Sale of Assets | 4.59 | 11.84 | 28.89 | 27.01 | 0.78 | 1.12 | Upgrade |
Asset Writedown | -65.6 | - | - | - | - | - | Upgrade |
Other Unusual Items | 25.7 | 25.89 | 1.55 | 32.74 | 55.2 | 2.84 | Upgrade |
Pretax Income | -1,065 | -1,358 | -2,492 | -2,675 | -595 | -1,672 | Upgrade |
Income Tax Expense | 0.39 | 22.55 | 43.99 | -93.11 | 135.53 | -3.82 | Upgrade |
Earnings From Continuing Operations | -1,066 | -1,380 | -2,536 | -2,582 | -730.53 | -1,669 | Upgrade |
Net Income to Company | -1,066 | -1,380 | -2,536 | -2,582 | -730.53 | -1,669 | Upgrade |
Minority Interest in Earnings | 115.83 | 99.18 | 252.26 | 196.03 | 9.62 | 0 | Upgrade |
Net Income | -949.86 | -1,281 | -2,283 | -2,386 | -720.91 | -1,669 | Upgrade |
Net Income to Common | -949.86 | -1,281 | -2,283 | -2,386 | -720.91 | -1,669 | Upgrade |
Shares Outstanding (Basic) | 991 | 985 | 984 | 917 | 890 | 822 | Upgrade |
Shares Outstanding (Diluted) | 991 | 985 | 984 | 917 | 890 | 822 | Upgrade |
Shares Change (YoY) | 0.47% | 0.11% | 7.28% | 3.08% | 8.28% | 5.58% | Upgrade |
EPS (Basic) | -0.96 | -1.30 | -2.32 | -2.60 | -0.81 | -2.03 | Upgrade |
EPS (Diluted) | -0.96 | -1.30 | -2.32 | -2.60 | -0.81 | -2.03 | Upgrade |
Free Cash Flow | -1,244 | -2,125 | -2,838 | -2,158 | -1,507 | -2,037 | Upgrade |
Free Cash Flow Per Share | -1.25 | -2.16 | -2.88 | -2.35 | -1.69 | -2.48 | Upgrade |
Gross Margin | 77.94% | 73.13% | 57.78% | 63.79% | 68.74% | 76.38% | Upgrade |
Operating Margin | -40.95% | -69.49% | -164.79% | -190.09% | -17.05% | -106.28% | Upgrade |
Profit Margin | -38.25% | -65.75% | -151.97% | -164.16% | -17.91% | -104.62% | Upgrade |
Free Cash Flow Margin | -50.08% | -109.06% | -188.85% | -148.50% | -37.44% | -127.71% | Upgrade |
EBITDA | -766.73 | -1,094 | -2,204 | -2,520 | -476.32 | -1,576 | Upgrade |
EBITDA Margin | -30.88% | -56.16% | -146.66% | -173.40% | -11.83% | -98.80% | Upgrade |
D&A For EBITDA | 250.14 | 259.65 | 272.32 | 242.54 | 209.74 | 119.31 | Upgrade |
EBIT | -1,017 | -1,354 | -2,476 | -2,763 | -686.06 | -1,695 | Upgrade |
EBIT Margin | -40.95% | -69.49% | -164.79% | -190.09% | -17.04% | -106.28% | Upgrade |
Revenue as Reported | 677.12 | 1,948 | 1,503 | - | 4,025 | 1,595 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.